|
|
||||||||

*
Faculty of Biology, University of Konstanz, Konstanz, Germany; and
F. Byk Gulden, Konstanz, Germany
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A variety of recognition molecules on the surface of apoptotic cells is important for the recognition and engulfment of the dying cells before membrane lysis. Parts of the genetic program for adhesion, uptake, and digestion by phagocytic cells seem to be genetically conserved from Caenorhabditis elegans to primates (8, 9). In the mammalian system, various recognition mechanisms have been described (3, 10, 11). It appears that a number of sequential processes similar to those of leukocyte rolling and sticking to endothelial cells or migration of cells (9, 12) are involved. Information on the specific contribution of different mechanisms in various cell types and tissues is still sparse. Candidate macrophage receptors for apoptotic cells include CD36/vitronectin together with thrombospondin (3, 10, 13), lectins (14), pattern recognition receptors such as scavenger receptors (15, 16), and CD14 (5, 17, 18). Target cells may signal their death to phagocytes by exposure of certain carbohydrates (19) or of phosphatidylserine (PS)3 (3) on the outer leaflet of the plasma membrane (20). PS exposure on the surface of apoptotic cells has been closely associated with activation of caspases (21), although a specific cleavage event has to date not been identified. In fact, measurement of PS exposure has become one of the most widely used parameters to characterize apoptotic cell populations (22, 23). Both caspase activation (24) and PS exposure triggered by active caspases have been considered as indispensible hallmarks of apoptosis, and as prerequisites for phagocytosis (25, 26), although this position is still matter of ongoing debate (27, 28).
In particular in pathological settings, cell death frequently occurs independent of caspases and may often be nonapoptotic (29). Information on recognition and uptake of dying cells in such situations is sparse. Sometimes such cells may not be taken up by phagocytes as intact entities (30), and their remainders may only be removed after more excessive breakdown (31). However, it is unknown whether phagocytosis of necrotic cells is generally precluded. We addressed this issue by triggering three different types of necrotic and caspase-independent cell death, and examined PS exposure and phagocytosis before and after membrane lysis. A special fluorescent assay to study phagocytosis of lysed cells was developed for this purpose.
| Materials and Methods |
|---|
|
|
|---|
Calcein-acetoxymethylester (calcein-AM), Hoechst-33342 (H-33342), octadecyl (C18) indocarbocyanine (DiI), and ethidium homodimer-1 (EH-1) were obtained from Molecular Probes (Eugene, OR). FITC-conjugated annexin V was obtained from Boehringer Mannheim (Mannheim, Germany). (+)- 5-Methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-5,10-imine (MK-801) came from RBI (Biotrend Chemikalien GmbH, Köln, Germany). N-acetyl-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin (DEVD-afc) was from Biomol (Hamburg, Germany). Benzoyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (zVAD-fmk) was purchased from Bachem Biochemica GmbH (Heidelberg, Germany). Rottlerin and calphostin C were from Calbiochem (Bad Soden, Germany). All other reagents were from Sigma (Deisenhofen, Germany), Merck (Darmstadt, Germany), or Riedel-de Haen (Seelze, Germany).
Preparation of monocyte-derived macrophages
Human monocytes were isolated as described previously
(32). In brief, 250 ml of peripheral venous blood was
drawn from a single volunteer. Citrate (0.31% w/v) was used as an
anticoagulant. The blood was diluted 1.6-fold with PBS (pH 7.4) before
centrifugation at 220 x g at 20°C for 20 min. The
cell pellet was layered on a Percoll gradient (
= 1.077 g/ml),
and the interphase containing the PBMC was obtained following
centrifugation at 800 x g for 10 min. Cells were
washed twice in elutriation medium (PBS, 2% heat-inactivated human AB
serum, 2 mM EDTA, 5 mM glucose (pH 7.4)) before countercurrent
centrifugal elutriation of the cells using a J2-MC centrifuge equipped
with a JE-6B rotor (Beckman, Fullerton, CA). The monocyte-containing
fraction was obtained at a flow rate of 39 ml x
min-1 and a rotor speed of
3000 rpm. Elutriated monocytes were plated at an initial density of
2 x 105 cells/well on 48-well culture
dishes. After 60 min at 37°C, nonadherent cells were removed and the
medium was exchanged for fresh RPMI 1640 containing 10%
heat-inactivated human AB serum (Sigma) and antibiotics (penicillin,
5000 IU/ml; streptomycin, 5 mg/ml). Monocytes were differentiated to
macrophages for 812 days in a volume of 1 ml/well on 48-well culture
dishes (32). Medium was exchanged 5 days after plating and
before experiments. Human monocyte-derived macrophages (HMDM) were used
for experiments between day 7 and 12 after plating.
Preparation of microglial cells
Wistar rat pups (12 days postpartum) were decapitated and the cerebrum was transferred to a buffer containing NaCl (137 mM), KCl (5.4 mM), Na2HPO4 (250 µM), KH2PO4 (235 µM), glucose (5 mM), and saccharose (58 mM) (pH 6.5) on ice. Following removal of meninges, brains were cut three times in different directions using a tissue chopper (Bachofer, Reutlingen, Germany) set to cut 400-µm thick pieces. The chopped tissue was digested in the presence of trypsin (0.5%), DNase I (0.05%), and MgSO4 (6 mM) for 5 min with subsequent trituration through a pipette tip to obtain a cell suspension. The mixed cell suspension was then maintained in Eagles basal medium supplemented with 10% FCS and antibiotics in 75-cm2 flasks (Primaria 3072; Becton Dickinson, Heidelberg, Germany) at a density of three brains/flask with medium change every 34 days. After 1014 days in culture, microglial cells were selectively detached by shaking at 150 rpm for 6 h. The supernatant was then transferred into FCS-coated 75-cm2 flasks, and microglial cells were allowed to adhere for 1 h. The supernatant was aspirated, adherent cells were removed by trypsinization, and resulting microglia were plated on 48-well dishes at a density of 2 x 105/well and used for experiments the following day. Purity was always >90%, as determined by routine staining with FITC-labeled lectin from Bandeiraea simplicifolia BS-I (33, 34).
Preparation and analysis of neuronal cultures
Murine cerebellar granule cells (CGC) were isolated as described (35, 36). Neurons were plated at a density of 0.25 x 106 cells/cm2 and cultured in Eagles basal medium (Life Technologies, Grand Island, NY) supplemented with 10% heat-inactivated FCS, KCl (20 mM), L-glutamine (2 mM), penicillin-streptomycin, and cytosine arabinoside (10 µM, added 48 h after plating). Neurons were used for experiments after 8 days in vitro without further medium change. PS staining of CGCs was performed as described (37, 38). In brief, cells grown on glass-bottom culture dishes were incubated with glutamate and inhibitors. After incubations, a mix of H-33342 (0.5 µg/ml) and EH-1 (0.3 µM) was added to the culture for 10 min, followed by washing of CGC and subsequent incubation with annexin V solution (1% in annexin V-binding buffer containing 100 mM HEPES/NaOH (pH 7.4), 140 mM NaCl, 2.5 mM CaCl2) in the dark for 2 min. Stained cultures were washed in binding buffer, and EH-1, H-33342, and fluorescein fluorescences were visualized simultaneously by confocal microscopy using a Leica DM-IRB microscope connected to a TCS-4D UV/VIS confocal scanning system (Leica AG, Benzheim, Germany). Ca2+ measurements with the indicator fura-2, and internal calibration were performed exactly as described (37, 38) using video imaging on an MCID system from Imaging Reasearch (St. Catherines, Ontario, Canada) equipped with a dage-72 (Dage-MTI, Michigan City, IN) camera and a computer-controlled filter wheel (Sutter, Novato, CA).
Jurkat cell culture and ATP levels
Jurkat cells (human T cell lymphoma, clone E6, ATCC No. TIB-152) were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated FCS, antibiotics (penicillin, 10,000 U/ml; streptomycin, 10 mg/ml), and glutamine (2 mM). All experiments were performed in RPMI 1640 without serum. ATP depletion was achieved by incubating Jurkat cells for 45 min in serum- and glucose-free medium in the presence of 2.5 µM oligomycin (39, 40). ATP was measured luminometrically exactly as described (39, 41).
PS exposure
Jurkat cells were seeded in 96-well plates at a density of 50,000 cells/well. After challenge, medium was replaced by annexin V-binding buffer containing fluorescein-conjugated annexin V (1.3% v/v), H-33342 (1 µg/ml), and EH-1 (1 µM). After one wash, three microscopic fields containing 100200 cells each were counted, excluding necrotic cells (EH-1 positive) from scoring.
Flow-cytometric analysis
In some experiments, cells were resuspended in 25 µl annexin buffer containing FITC-conjugated annexin V (1.3% v/v). After 5 min, 175 µl annexin buffer containing propidium iodide (10 µg/ml) was added. The cell suspension was analyzed by flow cytometry using a FACScalibur, as described (Becton Dickinson) (42).
Necrotic and apoptotic triggers
For all experiments, Jurkat cells were incubated in RPMI 1640 medium without serum. Apoptosis was triggered by addition of staurosporine (STS, 1 µM, 2 h), actinomycin D (ActD; 2 µg/ml, 10 h), camptothecin (10 µM, 10 h), or anti-CD95 Ab (CH-11, 100 ng/ml, 3 h). Treatment with ionomycin was performed by incubating Jurkat cells in annexin V-binding buffer containing ionomycin (2 µM) to achieve high [Ca2+]i conditions. Two types of delayed STS-triggered necrosis were induced. First, Jurkat cells were treated with STS in the presence of zVAD-fmk, as reported recently (43). Second, Jurkat cells were treated with STS under conditions of ATP depletion, as described previously (39, 44). NO-induced necrosis was achieved by incubating the cells in serum- and glucose-free medium containing pyruvate (2 mM) plus S-nitrosoglutathione (GSNO, 0.4 mM), as described (44), in the presence or absence of ActD (2 µg/ml) or camptothecine (10 µM). Quantification of apoptosis and necrosis was routinely performed by staining with a mixture of the cell-permeant chromatin dye H-33342 (blue, 0.5 µg/ml) and the membrane-impermeant dye SYTOX (green, 0.5 µM) (39). The percentage of necrotic cells (SYTOX-positive, noncondensed nuclei), early apoptotic (intact plasma membrane, condensed chromatin), and late apoptotic (SYTOX-positive, condensed, or fragmented nuclei) was determined by scoring 300500 cells in three to six different microscopic fields using a Leica microscope and lenses providing x400 final magnification. In some experiments, the membrane-impermeant dye EH-1 (red) was used instead of SYTOX (39).
Caspase activity
DEVD-afc cleavage activity was analyzed as described (45, 46) by lysing 2.5 x 105 Jurkat cells in a buffer containing HEPES (25 mM, pH 7.5), MgCl2 (5 mM), EGTA (1 mM), Triton X-100 (0.5%), leupeptin (1 µg/ml), pepstatin (1 µg/ml), aprotinin (1 µg/ml), and PEFA-block (1 mM). The lysates were transferred to a microtiter plate, and the fluorometric assay was performed with a substrate (DEVD-afc) concentration of 40 µM. DEVD-afc cleavage was monitored with an excitation wavelength of 390 nm and emission wavelength of 505 nm. The activity was calculated using calibration curves generated with free afc. One unit was defined as formation of 1 pmol afc.
Labeling of target cells for phagocytosis assays
Cells were stained with Fast Blue (1 µg/ml; Sigma) 1 day before treatment for at least 6 h. The cells were washed, and kept in fresh medium overnight. For some experiments, Jurkat cells were stained at the end of the toxic stimulation with 2 µM calcein-AM for 20 min. The dye was then removed by washing in medium before cells were added to macrophages.
Phagocytosis assay
Phagocytic cells (HMDM or microglia) were stained for 20 min with DiI (2.5 µg/ml) to visualize cell bodies. Jurkat cells (prelabeled with Fast Blue) were added to macrophages at a ratio of 10 (target):1, and phagocytosis was allowed to proceed for 1 h at 37°C. Nonphagocytosed target cells were then removed by five extensive washing steps in PBS or by exposure to trypsin (0.005% w/v) for 3 min at 37°C, and subsequent washing. Ingested cells were counted by their blue (Fast Blue) fluorescence in three to four microscopic fields containing 4080 phagocytes each. Phagocytic index was calculated by multiplying the percentage of phagocytosing cells with the average of ingested cells per phagocyte. All experiments with nonlysed target cells were performed in parallel with a different labeling strategy yielding essentially similar results: Jurkat cells were labeled with calcein-AM, as described, and used for the phagocytosis assay. This method allowed to confirm the maintenance of membrane integrity during the phagocytosis assay (necrotic cells lose calcein). Moreover, phagocytosed cells frequently seemed to be broken up in macrophages when left for more than 1 h. Then calcein spread throughout the macrophage, indicating that the target cell had really been ingested and not just adhered to the phagocyte.
Western blot analysis
The release of cytochrome c from Jurkat cell mitochondria was analyzed as described before (44, 47). At the indicated time points, Jurkat cells (1 x 106) were harvested and fractionated in cytosol and remaining organelles. Protein from the supernatants was separated on 15% polyacrylamide gels. Cytochrome c was detected by the enhanced chemoluminescence (ECL) reaction after blotting on nitrocellulose membranes with a mAb raised against pigeon cytochrome c (clone 7H8.2C12; PharMingen, San Diego, CA).
Statistical analysis
Phagocytosis experiments were run in quadruplicates and repeated in at least three cell preparations. Scoring was performed by two different observers blinded to the experimental conditions. Statistical significance was evaluated from the original data using Students t test. The Welch test was applied when variances were not homogenous within the compared groups. A p value of less than 0.05 was considered to be significant.
| Results |
|---|
|
|
|---|
To analyze phagocytosis of cells dying by different modes, we
designed a multiparameter fluorescent phagocytosis assay. Macrophages
were labeled with the lipophilic tracer DiI, which was bright, well
retained, and did not disturb phagocytosis function. Target cells were
labeled with Fast Blue, a dye of very low toxicity that has previously
been used as a neuronal tracer in vivo (48, 49). Fast
Blue-labeled cells retained the tracer dye even when the plasma
membrane was lysed (Fig. 1
A).
Chromatin condensation was quantitated in parallel cultures by staining
with H-33342 (39). The data were confirmed by Fast Blue
staining, which proved to be a good qualitative indicator of the
chromatin state of target cells in the phagocytosis assay (Fig. 1
A). In some experiments, loss of membrane integrity of
individual cells was additionally monitored by using either the red
fluorescent dye EH-1 or the green fluorescent dye SYTOX, which
selectively stained nuclei of cells with a lysed plasma membrane (Fig. 1
A). To evaluate the phagocytosis assay, we compared uptake
of control Jurkat cells and STS-challenged apoptotic cells. Only the
apoptotic cells were taken up and were clearly visible as blue spots
within phagocytic vacuoles of red macrophages (Fig. 1
B).
|
STS-triggered apoptosis of Jurkat cells can be diverted to
necrosis, when experiments are performed under conditions of ATP
depletion (39, 40, 50). To start our examinations, we used
this well-characterized model system to produce different modes of cell
death. Jurkat cells challenged with STS under normal metabolic
conditions (ATP high) activated caspases (DEVD-afc cleavage), condensed
their chromatin (>85% of the cells), and exposed PS (annexin V
positive) within 12 h. Plasma membrane integrity was retained for
45 h. When such cells were coincubated with HMDM after 2 h of
STS exposure, they were efficiently phagocytosed (Fig. 1
). Similar
correlations of apoptotic changes, PS exposure, and efficient
phagocytosis of nonlysed cells were obtained when cells were challenged
with ActD, camptothecin, or agonistic Abs against CD95 (not shown).
When cells were challenged with STS in the absence of glucose (low ATP)
and in the presence of oligomycin, an inhibitor of the mitochondrial
ATP synthase, they died necrotically (membrane lysis) after 45 h.
Compared with ATP-adequate cells, caspase activity, chromatin
condensation, and PS exposure were completely blocked in ATP-depleted,
prenecrotic cells 2 h after STS challenge (Fig. 2
) and did not increase until the cells
lysed. Such prenecrotic cells were not significantly phagocytosed (Fig. 2
A). Notably, in our experimental system, oligomycin did not
directly inhibit PS exposure or phagocytosis, as shown in other systems
(28, 51): cells treated with STS plus oligomycin in the
presence of glucose (high ATP) behaved exactly like cells treated with
STS alone (Fig. 2
). Those experiments corroborated the hypothesis that
apoptotic cells are taken up by macrophages, while prenecrotic
ATP-depleted ones are not.
|
When following the fate of the target cells throughout the
phagocytosis assay, we occasionally observed that some of the cells
losing their membrane integrity prematurely during the assay time were
engulfed by macrophages. Therefore, we tested what would happen, when
we used cells in the phagocytosis assay, that all had broken plasma
membranes. A population of pure necrotic cells was obtained by exposure
to STS under ATP-depleting conditions for 5 h (Fig. 2
D). Such late necrotic cells were efficiently taken up by
macrophages (Fig. 1
B). Most of the necrotic cells appeared
to be engulfed as single entities, similarly to the early apoptotic
cells (Fig. 1
B). Phagocytosis of necrotic Jurkat cells
killed by STS was as efficient as the one of early apoptotic cells
(Fig. 2
A). This implies that in certain types of necrosis,
cells do not necessarily have to disintegrate before their remnants are
removed. Rather, phagocytosis seems to be possible very quickly after
the loss of plasma membrane integrity.
We tested whether this phenomenon was also observed when cells were
killed independently of STS by the physiological NO donor GSNO. In
glucose-free medium, this substance triggered >85% necrosis within
24 h (41), independent of whether it was used alone
or in combination with the chemotherapeutics ActD and camptothecine.
Cells treated in the described manner were offered to HMDM for
phagocytosis (Fig. 3
). Also in this
model, necrotic Jurkat cells were efficiently phagocytosed once they
had lost plasma membrane integrity. These results suggest that
phagocytic uptake of necrotic cells may occur under different
pathological settings.
|
Inhibition of caspases has previously been shown to switch death
in lymphoid cells from apoptosis to necrosis (52, 53). In
Jurkat cells, STS-triggered apoptosis was switched to delayed necrosis
in the presence of the pan-caspase inhibitor zVAD-fmk
(43). We used this model to further study phagocytosis in
caspase-independent, nonapoptotic cell death. After 24-h stimulation,
such cells were efficiently phagocytosed (Fig. 4
A), although they did not
expose PS (Fig. 4
B). At that stage, cells had no condensed
chromatin, no significant caspase activity, adequate ATP levels (>70%
of control), and an apparently intact plasma membrane, although
cytochrome c had been released from mitochondria to the
cytosol (Fig. 4
C). The caspase inhibitor in the culture
supernatant was still functionally active ( 54 ; data not
shown).
|
Exposure of the phagocytosis marker PS in Ca2+-triggered cell death
PS exposure has been generally considered to be an event
controlled by caspase activation and specific for apoptotic death
(21, 55, 56). However, apart from caspases,
ionophore-mediated increases of
[Ca2+]i have been shown
to constitute an independent signal to trigger directly PS exposure and
phagocytosis signaling (25). We hypothesized that PS
exposure should occur before membrane lysis when necrotic/nonapoptotic
demise was triggered via disturbance of the Ca2+
homeostasis. To test the hypothesis, we challenged Jurkat cells with
the Ca2+ ionophore ionomycin. Indeed, cells
became annexin V positive within 1530 min (Fig. 5
A), and microscopic analysis
was corroborated by flow-cytometric analysis (Fig. 5
B). When
PS was exposed, the chromatin retained normal decondensed structure
(Fig. 5
C), and after 23 h, cells lysed without evident
apoptotic morphological changes or DNA fragmentation (not shown) or any
caspase activation (Fig. 5
D). The caspase independence of
ionomycin-triggered PS exposure was also tested in a further
experimental system. Cells were treated in glucose-free medium with STS
and oligomycin for 2 h. Under such conditions, caspase activation
is entirely prevented (see Fig. 2
c). Nevertheless, treatment
of such cells with ionomycin triggered PS exposure (7080% of the
cells after 30 min).
|
Similar events were observed in CGCs treated with lethal concentrations
(100 µM) of the excitotoxic neurotransmitter glutamate. Such
excitotoxic death has some features of apoptosis and some of necrosis
(57, 58). At 3060 min after triggering of
Ca2+ influx via the glutamate-controlled
N-methyl-D-aspartate receptor, most of
the cells (>90%) had translocated PS. The Ca2+
concentrations remained high, nuclei condensed within 6090 min (Fig. 6
), and plasma membrane integrity was
retained for 57 h. Cell death, chromatin condensation, and PS
exposure occurred independent of the activation of any known caspase,
since they were not affected by up to 100 µM zVAD-fmk (Fig. 6
). All
toxic events triggered by glutamate, including
Ca2+ influx, were prevented by preincubation with
the noncompetitive
N-methyl-D-aspartate receptor
antagonist MK-801. Taken together, these data suggest that increased
[Ca2+]i may trigger PS
exposure in cells dying by apoptosis or necrosis without necessitating
caspase activation.
|
PS exposure may either be sufficient alone for phagocytic uptake
of cells (26, 59) or be an indicator of other cell surface
changes important for recognition by phagocytes. Both possibilities
imply that ionomycin-challenged, annexin V-positve cells may be
recognized and engulfed by macrophages before lysis of their plasma
membrane, although they were nonapoptotic. We tested this hypothesis by
offering ionomycin-treated Jurkat cells to HMDM for ingestion. A
significant uptake occurred compared with nontreated control cells
(Fig. 7
A). Notably, the
targets were engulfed with still intact plasma membrane, as they
retained calcein during the phagocytosis procedure.
|
To distinguish between adhesion and ingestion of nonapoptotic cells by
macrophages, we used two methods. First, only adherent cells were
detached by trypsinization, and the large number of remaining target
cells indicated real engulfment. Second, we labeled them with calcein
and followed the fate of the dye. After prolonged (90-min) exposure of
calcein-labeled Jurkat cells to HMDM, macrophages were observed that
stained all green (Fig. 7
A), instead of just containing
distinct green target cells (see Fig. 4
D). After 3 h,
50% of the macrophages were green of calcein in the cytoplasm. This
can best be explained by release of the fluorescent label from the
target cell into the macrophage after complete phagocytosis and
initiation of digestion.
Phagocytosis by microglial cells
In a final set of experiments, we investigated whether genuine
tissue macrophages were also able to ingest nonapoptotic cells, and we
chose microglial cells, the professional neural phagocytes. Jurkat
cells were treated as described above either with ionomycin to induce
caspase-independent PS exposure, or with STS in the presence of
zVAD-fmk, or with STS under conditions of low cellular ATP levels, to
induce a prenecrotic state. Apoptotic control cells (STS exposure) were
substantially ingested by microglia (Fig. 8
). Ionomycin-treated cells were
phagocytosed to a lesser extent, whereas ATP-depleted, prenecrotic
cells failed to be taken up. Treatment of Jurkat cells with zVAD-fmk
and STS facilitated a significant uptake by microglial cells, but to a
lesser extent than observed with HMDM. These experiments essentially
confirmed that there may be multiple situations and pathways for
recognition and uptake of cells that do not die by classical apoptosis
and fail to activate caspases.
|
| Discussion |
|---|
|
|
|---|
In addition to the characterization of cell death, we further utilized a combination of dyes to label macrophages and target cells in a fluorescent phagocytosis assay. The main technical problems with many candidate dyes were the diffusion from one cell type to the other, and the potential loss of the label after membrane lysis. With respect to these problems, Fast Blue proved to be an optimal solution to label target cells. An additional advantage of the stain for this study was that it indicated changes of the chromatin structure. Although it was distributed throughout the cell in untreated Jurkats, it was very strongly accumulated in apoptotically condensed chromatin lumps, and allowed identification of the mode of death of cells directly used in the phagocytosis assay. Moreover, the study of different stages and modes of cell death was further facilitated by the addition of calcein-AM or of SYTOX. This allowed the identification of membrane intactness of individual cells during the phagocytosis experiment.
A notorious problem of all phagocytosis assays is the distinction of cells that adhere to macrophages from those that have been engulfed. Even though we used confocal microscopy, the question could not be solved unambiguously. We used two alternative approaches: first we introduced a trypsinization step, to detach all target cells that only bound to macrophages, but had not been taken up. The macrophages themselves were extremely trypsinization resistant after 812 days of differentiation on plastic. The large number of target cells remaining after trypsinization indicated that real phagocytosis had occurred. Second, we followed the fate of cells labeled with calcein-AM. Calcein-AM is converted to the fluorescent and membrane-impermeant dye calcein within live cells. Such cells retained the dye initially after being taken up into macrophages. At later stages, macrophages were observed that stained with calcein all over, indicating that the dye had been released into the phagocyte after uptake of the target cell. Taken together, these data suggest that mechanisms exist that allow the recognition and phagocytosis of prenecrotic cells by professional macrophages.
Quantitative phagocytosis assays would have been hardly possible in this study without the availability of experimental models that yielded a population of cells undergoing a well-characterized necrotic death with predictable and relatively synchronous kinetics. Thus, we were able to compare effects on a single cell line in three different necrotic models and in apoptosis triggered by four stimuli. Interestingly, necrotic cells seem to generate phagocytosis recognition signals in diverse ways, and efficiency of phagocytic uptake seems to be largely different between the models we used: 1) The absence of any PS exposure or phagocytic uptake of prenecrotic cells in the ATP-depletion model corroborates the frequently expressed view on the absence of any recognition mechanism in necrotic cells (6, 11, 64). However, it is remarkable in this context, that cells were recognized and taken up by macrophages relatively soon after lysis of their membrane. This may not prevent spillage of some intracellular contents from such dying cells, but necrotic cells may be removed quickly from tissues under certain conditions to allow immediate reorganization. 2) In the caspase-inhibition model, prenecrotic cells were phagocytosed in the absence of PS exposure. This would imply that PS exposure is not an indispensable requirement for phagocytosis of prenecrotic cells to occur. Also, in apoptotic cells, a number of different recognition mechanisms have been identified (3, 10), and it may depend on the cell types whether PS exposure is sufficient, necessary, or irrelevant for the engulfment by phagocytic cells (17, 26, 59, 65, 66, 67, 68, 69, 70). 3) The ionomycin model showed that PS exposure is not specific for apoptotic cells. It has been demonstrated earlier that inihibition of the aminophospholipid translocase by thiol-reactive agents would trigger PS exposure, and that such a mechanism may explain PS exposure in necrotic cells (71). Moreover, calcium has been implicated as a signal for PS exposure in apoptotic death and possibly in physiological situations (25, 72, 73). In this study, we complement this information by showing that PS exposure can occur in calcium-triggered necrotic death, even in the presence of high concentrations of the pan-caspase inhibitor zVAD, and that such cells are recognized and taken up by macrophages before membrane lysis. This model may have a correlate in a number of pathological settings, in which calcium has been suggested to be a key mediator of necrotic death (74, 75).
Calcium has also been implicated in apoptotic death (29, 74). Therefore, it was important to consider the possibility that ionomycin-triggered PS was in fact an apoptotic response. The mode of death triggered by calcium seems to depend on the intensity of insult (61, 63, 76), and on costimulatory signals. For instance, the combination of phorbol ester and ionomycin triggers apoptosis in lymphoid cells (77, 78), while ionomycin alone rather seems to inhibit apoptosis elicited by other stimuli (78, 79). We found in this study that ionomycin triggered clear necrosis. Thus, this experimental system also showed that phagocytosis can occur in caspase-independent modes of cell death that occur without any morphological indication of apoptosis.
Uptake of necrotic cells did obviously not correlate with PS exposure
in different experimental systems, although we found that it may occur
in special cases (Ca2+ stress). Some mechanistic
considerations appear to be interesting with respect to future studies:
1) Neither PS, nor other structures that would allow recognition by
macrophages, seem to be exposed in the ATP-depletion models. Possibly
energy-requiring steps are necessary, as for other apoptotic processes
(63). However, necrotic cells were taken up after rupture
of the plasma membrane. At present, we cannot exclude that this
mechanism may involve recognition of PS by macrophages. Membrane
asymmetry with respect to PS may be lost rapidly in necrotic cells, and
the methods available to us did not allow us to characterize this
process. 2) Earlier experiments in neurons (37, 54, 57)
and lymphoid cells (21) suggested that PS exposure
requires caspase activation. Although this holds true under many
experimental conditions, evidence has also been provided that either
cell type may become annexin V positive even when caspases are
inhibited (25, 57). In this study, we provided additional
evidence that there may be at least two different pathways of PS
exposure, one inhibitable by zVAD, and one inhibitable by PKC
inhibitors, but not by zVAD. The inhibitor pattern suggested some
specificity for the
isoform of PKC, and PKC
has before been
associated with various aspects of apoptosis (80, 81, 82, 83, 84). It
may be interesting to follow the role of PKC in necrotic PS exposure,
but more extensive studies are needed to really identify signal
transduction pathways and relevant molecular switches. We focused in
this study rather on the question on whether recognition by macrophages
may also be regulated by different drugs after different stimuli. In
fact, inhibition of ionomycin-triggered PS exposure by calphostin C,
but not by zVAD, correlated with the effect of these different drugs on
recognition and uptake of cells by macrophages.
A well-accepted dogma in cell death research has been the failure of phagocytes to remove necrotic cells. According to this scenario, lysing cells would constitute a danger for triggering inflammatory responses. A recent report showed that apoptosis was converted to necrosis in the interdigital space of mice either treated with caspase inhibitors or lacking apaf-1. Although phagocytosis of apoptotic cells could not occur in this study, no signs of inflammation were detected and fingers developed normally (30). This report suggests that there may be ways for a clean, silent removal of nonapoptotic cells. Our data expand this view by showing that there may be different ways and mechanisms for uptake of prenecrotic cells.
Apoptotic cells may under various circumstances also be ingested by neighboring cells instead of professional macrophages (3, 85, 86). From experiments in mice, it is known that in livers damaged by TNF, uptake of apoptotic hepatocytes is often a very conspicuous feature, while necrotic hepatocytes seem to remain untouched until their debris is taken up by invading leukocytes (31). This may constitute a major difference between apoptotic and necrotic death in certain tissues. In addition, the reaction and fate of phagocytes may be different after ingestion of apoptotic, necrotic, or microbial targets (5, 87, 88).
Different ways of recognition and uptake of dying cells may have a major implication on immunological parameters. It has been claimed for several years that presentation of Ags from apoptotic cells may represent a mechanism of initiation of autoimmune disease (89). It has also been suggested that different modes of cell death have an effect on systemic elimination of trypanosomes (90), on the maturation of dendritic cells (91), on Ag presentation by dendritic cells (91), and on macrophage antitumor activity (92). In most of those studies, the complexity of necrotic cell death has been avoided by the use of freeze-thawing as standard method to induce necrotic cells. Our study shows that the exact mode of necrotic death has an important impact on the recognition by phagocytes. This suggests that different forms of necrosis may alter major immunological reactions, such as autoimmunity, tumor regulation, and triggering of the T cell response.
During the last years, it has become evident that apoptosis and necrosis are not fundamentally different modes of cell death, but that in many instances, they may share initiation, signaling, and execution mechanisms (29, 58). Therefore, it has been difficult to find unambiguous biochemical or functional markers for the mode of cell death. The most clearly distinguishing features of apoptosis were the activation of caspases, and the selective uptake by phagocytes. Our data now show that phagocytosis is principally possible also in caspase-independent cell death. This may be important for many pathological situations, in which cell death frequently occurs by necrosis (29), and for chemotherapy, in which nonapoptotic death has been discussed to play an important role (93). Evidence for phagocytosis of necrotic cells supports the teleological view that mammalian organisms, in which cellular demise is less strictly dependent on caspases than in C. elegans, may have developed ways and means to efficiently remove apoptotic and necrotic cells, without major damage to the organism.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Marcel Leist, Faculty of Biology, University of Konstanz, X 911, D-78457 Konstanz, Germany. ![]()
3 Abbreviations used in this paper: PS, phosphatidylserine; ActD, actinomycin D; [Ca2+]i, intracellular calcium concentration; calcein-AM, calcein-acetoxymethyl ester; CGC, cerebellar granule cells; DEVD-afc, N-acetyl-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin; DiI, octadecyl (C18) indocarbocyanine; EH-1, ethidium homodimer-1; GSNO, S-nitrosoglutathione; H-33342, Hoechst-33342; HMDM, human monocyte-derived macrophage; MK-801, (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-5,10-imine; PKC, protein kinase C; STS, staurosporine; zVAD-fmk, benzoyloxycarbonyl-Val-Ala-Asp-fluoromethylketone. ![]()
Received for publication December 28, 1999. Accepted for publication March 30, 2000.
| References |
|---|
|
|
|---|
release by PDE inhibitors. Br. J. Pharmacol. 121:221.[Medline]
vß3). J. Immunol. 161:6250.
is essential for etoposide-induced apoptosis in salivary gland acinar cells. J. Biol. Chem. 274:19115.
is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J. Biol. Chem. 273:29995.
by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 184:2399.
by an ICE-like protease in apoptotic cells. EMBO J. 14:6148.[Medline]
plays a central role in neutrophil apoptosis. Blood 94:291.This article has been cited by other articles:
![]() |
M. F. Corsten, L. Hofstra, J. Narula, and C. P.M. Reutelingsperger Counting Heads in the War against Cancer: Defining the Role of Annexin A5 Imaging in Cancer Treatment and Surveillance Cancer Res., February 1, 2006; 66(3): 1255 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hegde, J. Roscoe, P. Cala, and F. Gorin Amiloride Kills Malignant Glioma Cells Independent of Its Inhibition of the Sodium-Hydrogen Exchanger J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 67 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hagge, N. A. Ray, J. L. Krahenbuhl, and L. B. Adams An In Vitro Model for the Lepromatous Leprosy Granuloma: Fate of Mycobacterium leprae from Target Macrophages after Interaction with Normal and Activated Effector Macrophages J. Immunol., June 15, 2004; 172(12): 7771 - 7779. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, S. Adachi, T. Imai, K.-i. Watanabe, S.-y. Toyokuni, M. Ueno, A. S. Zervos, G. Kroemer, and T. Nakahata A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity Blood, March 15, 2004; 103(6): 2299 - 2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brouckaert, M. Kalai, D. V. Krysko, X. Saelens, D. Vercammen, `M. Ndlovu, G. Haegeman, K. D'Herde, and P. Vandenabeele Phagocytosis of Necrotic Cells by Macrophages Is Phosphatidylserine Dependent and Does Not Induce Inflammatory Cytokine Production Mol. Biol. Cell, March 1, 2004; 15(3): 1089 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Liu, A. Takemasa, W. C. Liles, R. B. Goodman, M. Jonas, H. Rosen, E. Chi, R. K. Winn, J. M. Harlan, and P. I. Chuang Broad-spectrum caspase inhibition paradoxically augments cell death in TNF-alpha -stimulated neutrophils Blood, January 1, 2003; 101(1): 295 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nylandsted, W. Wick, U. A. Hirt, K. Brand, M. Rohde, M. Leist, M. Weller, and M. Jaattela Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion Cancer Res., December 15, 2002; 62(24): 7139 - 7142. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Davidson, C. Haudenschild, J. Kwon, and M. S. Williams T Cell Receptor Ligation Triggers Novel Nonapoptotic Cell Death Pathways That Are Fas-Independent or Fas-Dependent J. Immunol., December 1, 2002; 169(11): 6218 - 6230. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Willermain, L Caspers-Velu, B Nowak, P Stordeur, R Mosselmans, I Salmon, T Velu, and C Bruyns Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eye Br. J. Ophthalmol., December 1, 2002; 86(12): 1417 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Bateman, K. J. Harrington, T. Kottke, A. Ahmed, A. A. Melcher, M. J. Gough, E. Linardakis, D. Riddle, A. Dietz, C. M. Lohse, et al. Viral Fusogenic Membrane Glycoproteins Kill Solid Tumor Cells by Nonapoptotic Mechanisms That Promote Cross Presentation of Tumor Antigens by Dendritic Cells Cancer Res., November 15, 2002; 62(22): 6566 - 6578. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ferraro-Peyret, L. Quemeneur, M. Flacher, J.-P. Revillard, and L. Genestier Caspase-Independent Phosphatidylserine Exposure During Apoptosis of Primary T Lymphocytes J. Immunol., November 1, 2002; 169(9): 4805 - 4810. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Linardakis, A. Bateman, V. Phan, A. Ahmed, M. Gough, K. Olivier, R. Kennedy, F. Errington, K. J. Harrington, A. Melcher, et al. Enhancing the Efficacy of a Weak Allogeneic Melanoma Vaccine by Viral Fusogenic Membrane Glycoprotein-mediated Tumor Cell-Tumor Cell Fusion Cancer Res., October 1, 2002; 62(19): 5495 - 5504. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mateo, E. J. Brown, G. Biron, M. Rubio, A. Fischer, F. L. Deist, and M. Sarfati Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization Blood, September 26, 2002; 100(8): 2882 - 2890. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-G. Castaigne, W. Guo, C. Leveille, D. Charron, and R. Al-Daccak A CD18-dependent protein kinase C {beta}-mediated alternative cell death pathway of activated monocytes Int. Immunol., September 1, 2002; 14(9): 1003 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Magnus, A. Chan, O. Grauer, K. V. Toyka, and R. Gold Microglial Phagocytosis of Apoptotic Inflammatory T Cells Leads to Down-Regulation of Microglial Immune Activation J. Immunol., November 1, 2001; 167(9): 5004 - 5010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Lai, L.-J. Ho, K.-C. Lu, D.-M. Chang, M.-F. Shaio, and S.-H. Han Western and Chinese Antirheumatic Drug-Induced T Cell Apoptotic DNA Damage Uses Different Caspase Cascades and Is Independent of Fas/Fas Ligand Interaction J. Immunol., June 1, 2001; 166(11): 6914 - 6924. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Foghsgaard, D. Wissing, D. Mauch, U. Lademann, L. Bastholm, M. Boes, F. Elling, M. Leist, and M. Jaattela Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor J. Cell Biol., May 21, 2001; 153(5): 999 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Cocco and D. S. Ucker Distinct Modes of Macrophage Recognition for Apoptotic and Necrotic Cells Are Not Specified Exclusively by Phosphatidylserine Exposure Mol. Biol. Cell, April 1, 2001; 12(4): 919 - 930. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |